D M Evon

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence
    D M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Viral Hepat 20:536-49. 2013
  2. pmc A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment
    Donna M Evon
    Division of Gastroenterology and Hepatology, UNC School of Medicine, University of North Carolina at Chapel Hill, 27599, USA
    Am J Gastroenterol 106:1777-86. 2011
  3. pmc Barriers to accessing care in patients with chronic hepatitis C: the impact of depression
    D M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, USA
    Aliment Pharmacol Ther 32:1163-73. 2010
  4. doi request reprint Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study
    Donna M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA
    Am J Gastroenterol 104:2949-58. 2009
  5. doi request reprint Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre
    D M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Aliment Pharmacol Ther 27:1071-80. 2008
  6. ncbi request reprint High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities
    Donna M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Dig Dis Sci 52:3251-8. 2007
  7. ncbi request reprint Tobacco and alcohol use in lung transplant candidates and recipients
    Donna M Evon
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Clin Transplant 19:207-14. 2005
  8. pmc Social support and clinical outcomes during antiviral therapy for chronic hepatitis C
    Donna M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, United States
    J Psychosom Res 71:349-56. 2011
  9. ncbi request reprint Relationship between coping and depression in heart transplant candidates and their spouses
    Eileen J Burker
    University of North Carolina, Chapel Hill, NC, USA
    Prog Transplant 16:215-21. 2006
  10. ncbi request reprint Appraisal and coping as predictors of psychological distress and self-reported physical disability before lung transplantation
    Eileen J Burker
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Prog Transplant 14:222-32. 2004

Detail Information

Publications16

  1. pmc Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence
    D M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, USA
    J Viral Hepat 20:536-49. 2013
    ..These processes will be important to investigate as the dosing schedules of antiviral regimens become increasingly complex...
  2. pmc A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment
    Donna M Evon
    Division of Gastroenterology and Hepatology, UNC School of Medicine, University of North Carolina at Chapel Hill, 27599, USA
    Am J Gastroenterol 106:1777-86. 2011
    ..We sought to determine whether an integrated care intervention (INT) for patients deferred from PegIFN owing to MH/SA could improve subsequent treatment eligibility rates...
  3. pmc Barriers to accessing care in patients with chronic hepatitis C: the impact of depression
    D M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, USA
    Aliment Pharmacol Ther 32:1163-73. 2010
    ..Patients with hepatitis C viral (HCV) may perceive barriers to accessing speciality care for HCV, and these barriers may be related to depressive symptoms...
  4. doi request reprint Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study
    Donna M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, North Carolina 27599, USA
    Am J Gastroenterol 104:2949-58. 2009
    ..The objectives of this study were to determine the association between patient characteristics and depression before and during treatment and to evaluate the relationship between depression and treatment outcomes...
  5. doi request reprint Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre
    D M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Aliment Pharmacol Ther 27:1071-80. 2008
    ..The findings from these lines of research may not be generalizable to patients treated under standard of care in a tertiary care setting...
  6. ncbi request reprint High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities
    Donna M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Dig Dis Sci 52:3251-8. 2007
    ..When patients are deferred for PI/SA but later treated, they have significantly higher rates of not completing treatment and a trend toward lower SVR rates...
  7. ncbi request reprint Tobacco and alcohol use in lung transplant candidates and recipients
    Donna M Evon
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Clin Transplant 19:207-14. 2005
    ..Smoking and drinking behaviors were related to demographic variables, depression, and low social support...
  8. pmc Social support and clinical outcomes during antiviral therapy for chronic hepatitis C
    Donna M Evon
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, United States
    J Psychosom Res 71:349-56. 2011
    ..To determine if social support (SS) is associated with clinical outcomes during antiviral therapy for chronic hepatitis C virus (HCV)...
  9. ncbi request reprint Relationship between coping and depression in heart transplant candidates and their spouses
    Eileen J Burker
    University of North Carolina, Chapel Hill, NC, USA
    Prog Transplant 16:215-21. 2006
    ..Depression in this group of patients is important because heart transplant patients with preoperative depression have been found to have a higher mortality rate after transplantation...
  10. ncbi request reprint Appraisal and coping as predictors of psychological distress and self-reported physical disability before lung transplantation
    Eileen J Burker
    University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Prog Transplant 14:222-32. 2004
    ....
  11. pmc Reliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimens
    J E Bonner
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
    J Viral Hepat 19:316-26. 2012
    ..The four-factor structure suggests different types of efficacy beliefs may function during HCV treatment and should be explored further in relation to clinical outcomes...
  12. ncbi request reprint Religious and non-religious coping in lung transplant candidates: does adding god to the picture tell us more?
    Eileen J Burker
    Department of Allied Health Sciences, Medical School Wing E, University of North Carolina at Chapel Hill, 27599 7205, USA
    J Behav Med 28:513-26. 2005
    ..Our findings suggest that NRC and RC are independent components of psychological functioning, and measuring both coping styles provides more information than studying each alone...
  13. ncbi request reprint Coping predicts depression and disability in heart transplant candidates
    Eileen J Burker
    Department of Allied Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7205, USA
    J Psychosom Res 59:215-22. 2005
    ..The aim of this study was to describe the coping strategies used by cardiac patients who are pursuing heart transplant and to determine which coping strategies are related to depression and self-reported disability...
  14. ncbi request reprint Health locus of control predicts survival after lung transplant
    Eileen J Burker
    Department of Allied Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7205, USA
    J Health Psychol 10:695-704. 2005
    ..Neither PHLC nor CHLC exhibited statistical differences in survival. Compared to patients with low IHLC, patients with medium and high levels of IHLC lived longer after lung transplant...
  15. ncbi request reprint Depression in primary caregivers of patients listed for liver or kidney transplantation
    Ahmed Bolkhir
    Saint Louis University School of Medicine, Saint Louis, MO, USA
    Prog Transplant 17:193-8. 2007
    ..No studies have examined depression in primary caregivers of adult patients listed for liver or kidney transplantation...
  16. ncbi request reprint Process and outcome in cardiac rehabilitation: an examination of cross-lagged effects
    Donna M Evon
    Department of Psychology, Finch University of Health Sciences Chicago Medical School, Chicago, IL 60064, USA
    J Consult Clin Psychol 72:605-16. 2004
    ..Findings suggest that increased exercise self-efficacy represents an important therapeutic mechanism by which rehabilitation gains are realized. ((c) 2004 APA, all rights reserved)..